RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

计划入组 30 人 · 首次发布于 2025 年 9 月 2 日

Embolization for Meningioma

计划入组 30 人 · 首次发布于 2022 年 6 月 13 日

Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma

计划入组 18 人 · 首次发布于 2009 年 9 月 4 日

Thiopental

C₁₁H₁₈N₂O₂S

Nimodipine(Nimotop, Nymalize)

C₂₁H₂₆N₂O₇ · Rx

Mannitol(Aridol, Bronchitol, Cystosol, Osmitrol, Sag-M)

<dd class="col-xl-8 col-md-9 col-sm-8">C₆H₁₄O₆</dd> · Rx

Lutetium Lu 177 Dotatate Demonstrates Significant Efficacy in Advanced Intracranial Meningioma Phase 2 Trial

New Study Links Depo-Provera to Doubled Brain Tumor Risk as Pfizer Faces Over 1,200 Lawsuits

Pfizer Faces Legal Challenges as Study Links Depo-Provera to Increased Meningioma Risk